Form 4: Predictive Oncology Inc. Director Veena Rao Reports Stock Transactions
SEC Form 4 Filing
Director Veena Rao of Predictive Oncology Inc. reports acquiring and disposing of common stock on April 5, 2024.
Summary
- On April 5, 2024, Veena Rao, a director of Predictive Oncology Inc., engaged in transactions involving the company's common stock.
- Rao acquired 3,268 shares of common stock.
- Rao disposed of 9,117 shares of common stock.
- Following these transactions, Rao beneficially owns 9,117 shares of Predictive Oncology Inc.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a standard SEC Form 4 filing, which is a routine part of corporate governance and transparency, providing insight into the trading activities of company insiders.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company insider.
Key Dates
| Date | Description |
|---|---|
| 04/05/2024 | Date of stock transactions (acquisition and disposition). |
| 04/12/2024 | Date of signature for the report. |
Keywords
Predictive Oncology Inc., POAI, Veena Rao, Director, Stock Transaction, Beneficial Ownership, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.